Cervical lymph node biopsies in the evaluation of children with suspected lymphoproliferative disorders: Experience in a tertiary pediatric setting
jpedsurg.org shows its articles on its own site.
Read the article on jpedsurg.org ↗Article · Sep 2021 · 1 min read
In brief
In brief
Retrospective study examining cervical lymph node biopsies in children at a tertiary center (2012-2019) found malignancy in 49.5% of cases. Analysis identifies demographic, clinical, and imaging characteristics that distinguish benign from malignant lymphoproliferative disorders in pediatric patients requiring biopsy.
Written by the GCMD Library team from the article.
Background/Purpose: The objectives of this study were: 1) to determine the incidence of lymphoproliferative disorders in a cohort of patients requiring a biopsy at a tertiary pediatric center; and 2) to elucidate the demographic, clinical, laboratory and diagnostic imaging characteristics associated with a malignant diagnosis.
Methods: A retrospective review of pediatric cervical lymph node biopsies performed between 2012 and 2019 at a tertiary center was undertaken. Demographic data, clinical presentations, laboratory results, diagnostic imaging findings, and pathology results were compiled and analyzed to identify characteristics associated with a malignant diagnosis.
Results: Malignancy was identified in 49.5% of patients (55/111) subjected to a cervical lymph node biopsy. The median age of patients with a benign diagnosis was lower than malignant diagnosis (11.0 vs. 14.0 years, p